Related Experiment Videos

Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy

Dekui Zhang1, Justin L Mott, Patricia Farrar

  • 1Department of Molecular Microbiology and Immunology, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, St. Louis, MO 63104, USA.

Cardiovascular Research
|December 31, 2002
PubMed
Abstract

Insights

Mitochondrial DNA (mtDNA) mutations are pathogenic, causing severe heart disease and cell death in mice. These mutations trigger apoptosis, a programmed cell death pathway, through the mitochondria.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations are implicated in various diseases.
  • The pathogenicity of low-frequency mtDNA mutations remains unclear.

Purpose of the Study:

  • To investigate whether low-frequency mitochondrial DNA (mtDNA) mutations are pathogenic.
  • To elucidate the mechanism by which mtDNA mutations affect cardiac health.

Main Methods:

  • Studied mice engineered to express a proofreading-deficient mitochondrial DNA polymerase in the heart.
  • Induced cardiac mtDNA mutations and analyzed their effects on cardiac function and histology.

Main Results:

  • Mice developed severe dilated cardiomyopathy and interstitial fibrosis by 4 weeks of age.
  • Apoptosis (programmed cell death) was observed in cardiac myocytes, indicated by TUNEL staining.
  • Cytochrome c release from mitochondria, a pro-apoptotic signal, occurred despite normal mitochondrial respiratory function.

Conclusions:

  • Mitochondrial DNA (mtDNA) mutations are confirmed as pathogenic.
  • These mutations appear to trigger apoptosis via the intrinsic mitochondrial pathway.

Related Concept Videos